Based on the recommendations of Foreign Investment Promotion Board (FIPB), the government in its meeting chaired by Economic Affairs Secretary Shaktikanta Das, has approved five Foreign Direct Investment proposals amounting Rs 6,050 crore, including Cadila Healthcare with investment of Rs. 5,000-crore for fresh equity infusion. Cadila will infuse equity of up to Rs. 5,000 crore through issue of shares to QIBs through Qualified Institutional Placement for expansion.
Besides, other proposals which were approved includes Sai Life Sciences which sought approval for Alpha TC Holdings to transfer its shares held in Sai Life to its wholly-owned subsidiary (WoS) Alpha FDI Holdings and deletion of condition of compounding by the Reserve Bank of India imposed in the approval letter, Health Media Publishing which sought approval for the transfer of its 99.90% shares currently held by Mr Ajit Patel, an NRI to Wellness Technology and Media Private, UK.
The other major proposal approved was of Recipharm Participation BV for incorporating a WoS in India. The pharma firm’s proposal worth Rs. 1,050 crore also included the WoS buying out promoter stake in Nitin Lifesciences and increasing foreign equity to 74 per cent. Also approved was Buimerc Core Investments proposal for transferring of 100 per cent equity shares of NRI investors and Resident Investors to Buimerc Corporation FZE.
Meanwhile, FIPB deferred six FDI proposals including Gulf Quarry General Trading F.Z.C., International Asset Reconstruction Company, Raheja QBE General Insurance Company, Equitas Holding, HSBC Securities and Capital Markets (India) and Holcim (India). However, FIPB rejected two proposals including Nigeria’s Mokeme Chiwetal Izuchukwu and Lanarth Developers.
.